5,825
Views
88
CrossRef citations to date
0
Altmetric
Review

Chitosan and its derivatives as vehicles for drug delivery

, &
Pages 108-113 | Received 25 Sep 2017, Accepted 28 Oct 2017, Published online: 10 Nov 2017

References

  • Alishahi A, Mirvaghefi A, Tehrani MR, et al. (2011). Chitosan nanoparticle to carry vitamin C through the gastrointestinal tract and induce the non-specific immunity system of rainbow trout (Oncorhynchus mykiss). Carbohydrate Polym 86:142–6.
  • Anitha A, Maya S, Deepa N, et al. (2012). Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery. J Biomater Sci Polym Ed 23:1381–400.
  • Ayensu I, Mitchell JC, Boateng JS. (2012). Development and physico-mechanical characterisation of lyophilised chitosan wafers as potential protein drug delivery systems via the buccal mucosa. Colloids Surf B: Biointerf 91:258–65.
  • Bhargava M, Bhargava S, Jain S, Jain R. (2015). P032: development and characterization of surface modified chitosan nanoparticles for selective targeting of lamivudine to hepatocyte. J Viral Hepatitis 22:35.
  • Bhattarai N, Gunn J, Zhang M. (2010). Chitosan-based hydrogels for controlled, localized drug delivery ⋆. Adv Drug Deliv Rev 62:83–99.
  • Calderón L, Harris R, Cordoba-Diaz M, et al. (2013). Nano and microparticulate chitosan-based systems for antiviral topical delivery. Eur J Pharmaceut Sci 48:216–22.
  • Cheng YH, Hung KH, Tsai TH, et al. (2014). Sustained delivery of latanoprost by thermosensitive chitosan-gelatin-based hydrogel for controlling ocular hypertension. Acta Biomater 10:4360–6.
  • Duceppe N, Tabrizian M. (2010). Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery. Expert Opin Drug Deliv 7:1191–207.
  • Feng C, Wang Z, Jiang C, et al. (2013). Chitosan/O-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: In vitro and in vivo evaluation. Int J Pharmaceut 457:158–67.
  • Forbes DC, Peppas NA. (2014). Polymeric nanocarriers for sirna delivery to murine macrophages. Macromol Biosci 14:1096–105.
  • Gratieri T, Gelfuso GM, Freitas OD, et al. (2011). Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel. Eur J Pharm Biopharm 79:320–7.
  • Grenha A, Gomes ME, Rodrigues M, et al. (2010). Development of new chitosan/carrageenan nanoparticles for drug delivery applications. J Biomed Mater Res A 92:1265–72.
  • Hu Y, Liu N, Tan Y, Hu F. (2016). Selective redox-responsive siRNA delivery mediated by chitosan based glycolipid-like nanocarrier. Nanomedicine 12:549–50.
  • Katas H, Raja MAG, Kai LL. (2013). Development of chitosan nanoparticles as a stable drug delivery system for protein/siRNA. Int J Biomater 2013:146320.
  • Kawadkar J, Jain R, Kishore R, et al. (2013). Formulation and evaluation of flurbiprofen-loaded genipin cross-linked gelatin microspheres for intra-articular delivery. J Drug Target 21:200–10.
  • Khodadust R, Unsoy G, Gunduz U. (2014). Development of poly (I:C) modified doxorubicin loaded magnetic dendrimer nanoparticles for targeted combination therapy. Biomed Pharmacother 68:979–87.
  • Kono H, Teshirogi T. (2015). Cyclodextrin-grafted chitosan hydrogels for controlled drug delivery. International Int J Biol Macromol 72:299–308.
  • Lam PL, Lee KK, Wong RS, et al. (2012). Development of hydrocortisone succinic acid/and 5-fluorouracil/chitosan microcapsules for oral and topical drug deliveries. Bioorg Med Chem Lett 22:3213–18.
  • Lee BR, Oh KT, Baik HJ, et al. (2010). A charge-switched nano-sized polymeric carrier for protein delivery. Int J Pharmaceut 392:78–82.
  • Lee JH, Lee CK, Bae SH, et al. (2011). Preparation and characterization of self-assembled glycol chitosan hydrogels containing palmityl-acylated exendin-4 for extended hypoglycemic action. J Pharmaceut Investig 41:173–8.
  • Liu Z, Jiao Y, Zhang Z. (2010). Calcium-carboxymethyl chitosan hydrogel beads for protein drug delivery system. J Appl Polym Sci 103:3164–8.
  • Lü S, Liu M, Ni B. (2010). An injectable oxidized carboxymethylcellulose/n-succinyl-chitosan hydrogel system for protein delivery. Chem Eng J 160:779–87.
  • Mei LT, Choong PFM, Dass CR. (2009). Review: doxorubicin delivery systems based on chitosan for cancer therapy. J Pharm Pharmacol 61:131–42.
  • Mengatto LN, Helbling IM, Luna JA. (2012). Recent advances in chitosan films for controlled release of drugs. Recent Pat Drug Deliv Formul 6:156–70.
  • Millotti G, Perera G, Vigl C, et al. (2011). The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery. Drug Deliv 18:190–7.
  • Mouez MA, Zaki NM, Mansour S, Geneidi AS. (2014). Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres. Eur J Pharmaceut Sci 51:59–66.
  • Patil SB, Sawant KK. (2011). Chitosan microspheres as a delivery system for nasal insufflation. Colloids Surf B Biointerfaces 84:384–9.
  • Pengpong T, Sangvanich P, Sirilertmukul K, Muangsin N. (2014). Design, synthesis and in vitro evaluation of mucoadhesive p-coumarate-thiolated-chitosan as a hydrophobic drug carriers. Eur J Pharm Biopharm 86:487–97.
  • Rajesh R, Rekha MR, Sharma CP. (2012). Evaluation of lauryl chitosan graft polyethyleneimine as a potential carrier of genes and anticancer drugs. Process Biochem 47:1079–88.
  • Rani M, Agarwal A, Negi YS. (2010). Chitosan based hydrogel polymeric beads - as drug delivery system. Bioresources 5:2765–807.
  • Riva R, Ragelle H, Rieux AD, et al. (2011). Chitosan and chitosan derivatives in drug delivery and tissue engineering. Adv Polym Sci 244:19–44.
  • Saranya N, Moorthi A, Saravanan S, et al. (2011). Chitosan and its derivatives for gene delivery. Int J Biol Macromol 48:234–8.
  • Saravana KA, Ramaswamy NM. (2011). Chitosan microspheres as potential vaccine delivery systems. Int J Drug Del 3:43–50.
  • Sezer AD, Cevher E. (2012). Topical drug delivery using chitosan nano- and microparticles. Expert Opin Drug Deliv 9:1129–46.
  • Shen JM, Tang WJ, Zhang XL, et al. (2012). Novel carboxymethyl chitosan-based folate/Fe3O4/CdTe nanoparticle for targeted drug delivery and cell imaging. Carbohydrate Polym 88:239–49.
  • Siafaka PI, Titopoulou A, Koukaras EN, et al. (2015). Chitosan derivatives as effective nanocarriers for ocular release of timolol drug. Int J Pharmaceut 495:249–64.
  • Sonia TA, Sharma CP. (2011). Chitosan and its derivatives for drug delivery perspective. Adv Polym Sci 243:23–53.
  • Supper S, Anton N, Boisclair J, et al. (2014). Chitosan/glucose 1-phosphate as new stable in situ forming depot system for controlled drug delivery. Eur J Pharm Biopharm 88:361–73.
  • Termsarasab U, Yoon IS, Park JH, et al. (2014). Polyethylene glycol-modified arachidyl chitosan-based nanoparticles for prolonged blood circulation of doxorubicin. Int J Pharmaceut 464:127–34.
  • Toh EK, Chen HY, Lo YL, et al. (2011). Succinated chitosan as a gene carrier for improved chitosan solubility and gene transfection. Nanomedicine 7:174–83.
  • Umadevi SK, Thiruganesh R, Suresh S, Reddy KB. (2010). Formulation and evaluation of chitosan microspheres of aceclofenac for colon-targeted drug delivery. Biopharm Drug Dispos 31:407–27.
  • Varshosaz J. (2007). The promise of chitosan microspheres in drug delivery systems. Expert Opin Drug Deliv 4:263–73.
  • Vivek R, Babu VN, Thangam R, et al. (2013). Ph-responsive drug delivery of chitosan nanoparticles as tamoxifen carriers for effective anti-tumor activity in breast cancer cells. Colloids Surf B Biointerf 111:117–23.
  • Wang C, Mallela J, Garapati US, et al. (2013). A chitosan-modified graphene nanogel for noninvasive controlled drug release. Nanomedicine 9:903–11.
  • Wang J, Chen JS, Zong JY, et al. (2010). Calcium carbonate/carboxymethyl chitosan hybrid microspheres and nanospheres for drug delivery. J Phys Chem C 114:18940–5.
  • Wassmer S, Rafat M, Fong WG, et al. (2013). Chitosan microparticles for delivery of proteins to the retina. Acta Biomater 9:7855–64.
  • Xing ZH. (2013). Preparation and characterization of folate modified-chitosan nanoparticles as new tumor-targeting drug carrier. Asian J Chem 25:9532–6.
  • Xing ZH. (2013). Preparation and characterization of folate-decorated chitosan microspheres as a sustained-release drugs carrier. Amr 684:57–62.
  • Yadollahi M, Farhoudian S, Namazi H. (2015). One-pot synthesis of antibacterial chitosan/silver bio-nanocomposite hydrogel beads as drug delivery systems. Int J Biol Macromol 79:37–43.
  • Yang J, Chen J, Pan D, et al. (2013). pH-sensitive interpenetrating network hydrogels based on chitosan derivatives and alginate for oral drug delivery. Carbohydrate Polym 92:719–25.
  • Zhang J, Tang Q, Xu X, Li N. (2013). Development and evaluation of a novel phytosome-loaded chitosan microsphere system for curcumin delivery. Int J Pharm 448:168–74.
  • Zhao X, Li Z, Pan H, et al. (2013). Enhanced gene delivery by chitosan-disulfide-conjugated LMW-PEI for facilitating osteogenic differentiation. Acta Biomater 9:6694–703.
  • Zhou N, Zan X, Wang Z, et al. (2013). Galactosylated chitosan-polycaprolactone nanoparticles for hepatocyte-targeted delivery of curcumin. Carbohydrate Polym 94:420–9.